The Brain Health Study: A Pragmatic, Patient-Centered Trial

Alzheimer Disease Clinical Trial

Official title: Low-cost Detection of Dementia Using Electronic Health Records Data: Validation and Testing of the eRADAR Algorithm in a Pragmatic, Patient-centered Trial.

Status Active, not recruiting

Clinical Trial Summary

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Clinical Trial Description

eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. We will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. We will also explore the impact of eRADAR implementation on healthcare utilization and patient experience. ;

Related Conditions & MeSH terms

• Alzheimer Disease
• Dementia

• NCT number: NCT05356702
• Study type: Interventional
• Source: Kaiser Permanente
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 29, 2022
• Completion date: July 31, 2025